Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion type Assertion NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_head.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion description "[Thus high HIF1? expression serves as a reliable marker, which identifies patients with a poor prognosis in an otherwise prognostically favorable AML group and represents an innovative therapeutic target in high-risk A/E-driven leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_provenance.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion evidence source_evidence_literature NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_provenance.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion SIO_000772 25727291 NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_provenance.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion wasDerivedFrom befree-2016 NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_provenance.
- NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_assertion wasGeneratedBy ECO_0000203 NP1267204.RA8K584ailn0pD40H2QWL9UrCD9gVEqQXuKJJz_Pb6yLY130_provenance.